HLA-DR2 predicts a favorable response to cyclosporine therapy in patients with bone marrow failure.
Nakao
S
S
Yamaguchi
M
M
Saito
M
M
Yasue
S
S
Shiobara
S
S
Matsuda
T
T
Nitta
M
M
Sasaki
M
M
D001855:Bone Marrow Diseases / Q000188:drug therapy* / Q000276:immunology*; D016572:Cyclosporine / Q000627:therapeutic use*; D015802:HLA-DR2 Antigen / Q000032:analysis*
D015802:HLA-DR2 Antigen; D016572:Cyclosporine